BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Supic G, Kozomara R, Zeljic K, Jovic N, Magic Z. Prognostic value of the DNMTs mRNA expression and genetic polymorphisms on the clinical outcome in oral cancer patients. Clin Oral Invest 2017;21:173-82. [DOI: 10.1007/s00784-016-1772-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Supic G, Zeljic K, Magic Z. Epigenetic Nutraceuticals in Cancer Treatment. Therapeutic Foods. Elsevier; 2018. pp. 449-93. [DOI: 10.1016/b978-0-12-811517-6.00015-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Gaździcka J, Gołąbek K, Strzelczyk JK, Ostrowska Z. Epigenetic Modifications in Head and Neck Cancer. Biochem Genet 2020;58:213-44. [PMID: 31712935 DOI: 10.1007/s10528-019-09941-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
3 Piyathilake CJ, Badiga S, Borak SG, Weragoda J, Bae S, Matthews R, Bell WC, Partridge EE. A higher degree of expression of DNA methyl transferase 1 in cervical cancer is associated with poor survival outcome. Int J Womens Health 2017;9:413-20. [PMID: 28652820 DOI: 10.2147/IJWH.S133441] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
4 Maric H, Supic G, Kandolf-Sekulovic L, Maric V, Mijuskovic Z, Radevic T, Rajovic M, Magic Z. DNMT1 and DNMT3B genetic polymorphisms affect the clinical course and outcome of melanoma patients. Melanoma Res 2019;29:596-602. [PMID: 30950914 DOI: 10.1097/CMR.0000000000000612] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
5 Flausino CS, Daniel FI, Modolo F. DNA methylation in oral squamous cell carcinoma: from its role in carcinogenesis to potential inhibitor drugs. Crit Rev Oncol Hematol 2021;164:103399. [PMID: 34147646 DOI: 10.1016/j.critrevonc.2021.103399] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Nasry WHS, Rodriguez-Lecompte JC, Martin CK. Role of COX-2/PGE2 Mediated Inflammation in Oral Squamous Cell Carcinoma. Cancers (Basel) 2018;10:E348. [PMID: 30248985 DOI: 10.3390/cancers10100348] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 7.8] [Reference Citation Analysis]
7 Lai Q, Xu YH, Chen Q, Tang L, Li AG, Zhang LF, Zhang CF, Song JF, Du ZZ. The loss-of-function of DNA methyltransferase 1 by siRNA impairs the growth of non-small cell lung cancer with alleviated side effects via reactivation of RASSF1A and APC in vitro and vivo. Oncotarget 2017;8:59301-11. [PMID: 28938637 DOI: 10.18632/oncotarget.19573] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
8 Hurník P, Chyra Z, Ševčíková T, Štembírek J, Trtková KS, Gaykalova DA, Buchtová M, Hrubá E. Epigenetic Regulations of Perineural Invasion in Head and Neck Squamous Cell Carcinoma. Front Genet 2022;13:848557. [DOI: 10.3389/fgene.2022.848557] [Reference Citation Analysis]
9 Cardenas H, Fang F, Jiang G, Perkins SM, Zhang C, Emerson RE, Hutchins G, Keer HN, Liu Y, Matei D, Nephew K. Methylomic Signatures of High Grade Serous Ovarian Cancer. Epigenetics 2020;:1-16. [PMID: 33289590 DOI: 10.1080/15592294.2020.1853402] [Reference Citation Analysis]
10 Tan D, Sheng L, Yi Q. Correlation of PD-1/PD-L1 polymorphisms and expressions with clinicopathologic features and prognosis of ovarian cancer. CBM 2018;21:287-97. [DOI: 10.3233/cbm-170357] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
11 Feng C, Ho Y, Sun C, Xia G, Ding Q, Gu B. Epigallocatechin gallate inhibits the growth and promotes the apoptosis of bladder cancer cells. Exp Ther Med 2017;14:3513-8. [PMID: 29042941 DOI: 10.3892/etm.2017.4981] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
12 Xiong M, Pan B, Wang X, Nie J, Pan Y, Sun H, Xu T, Cho WC, Wang S, He B. Susceptibility of Genetic Variations in Methylation Pathway to Gastric Cancer. PGPM 2022;Volume 15:441-8. [DOI: 10.2147/pgpm.s340941] [Reference Citation Analysis]
13 Chakraborty B, Mukhopadhyay D, Roychowdhury A, Basu M, Alam N, Chatterjee K, Chakrabarti J, Panda CK. Differential Wnt-β- catenin pathway activation in HPV positive and negative oral epithelium is transmitted during head and neck tumorigenesis: clinical implications. Med Microbiol Immunol 2021;210:49-63. [PMID: 33226516 DOI: 10.1007/s00430-020-00697-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Dongoran RA, Wang KH, Lin TJ, Yuan TC, Liu CH. Anti-Proliferative Effect of Statins Is Mediated by DNMT1 Inhibition and p21 Expression in OSCC Cells. Cancers (Basel) 2020;12:E2084. [PMID: 32731382 DOI: 10.3390/cancers12082084] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Fathima T, Arumugam P, Girija As S, Priyadharsini JV. Decoding the Genetic Alterations in Genes of DNMT Family (DNA Methyl-Transferase) and their Association with Head and Neck Squamous Cell Carcinoma. Asian Pac J Cancer Prev 2020;21:3605-12. [PMID: 33369458 DOI: 10.31557/APJCP.2020.21.12.3605] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Burkitt K, Saloura V. Epigenetic Modifiers as Novel Therapeutic Targets and a Systematic Review of Clinical Studies Investigating Epigenetic Inhibitors in Head and Neck Cancer. Cancers (Basel) 2021;13:5241. [PMID: 34680389 DOI: 10.3390/cancers13205241] [Reference Citation Analysis]